A 73-year-old male with end-stage heart failure underwent insertion of the HeartMate 3 (Abbott, North Chicago, IL, USA) device. Systemic anticoagulation and antiplatelets were discontinued for 52 days due to postoperative bleeding. After hemorrhage resolution, we restarted warfarin monotherapy targeting an international normalized ratio of 1.8-2.5. Eight months later, there are no reports of pump thrombosis, thromboembolism, and bleeding.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462652 | PMC |
| http://dx.doi.org/10.7759/cureus.28779 | DOI Listing |
Publication Analysis
Top Keywords
long-term withdrawal
4
withdrawal anticoagulation
4
anticoagulation antiplatelet
4
antiplatelet therapy
4
therapy heartmate
4
heartmate left
4
left ventricular
4
ventricular assist
4
assist device
4
device 73-year-old
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!